EPOCH BIOSCIENCES INC
10QSB, EX-27.1, 2000-11-14
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Previous: EPOCH BIOSCIENCES INC, 10QSB, EX-10.1, 2000-11-14
Next: QUEENS COUNTY BANCORP INC, 10-Q, 2000-11-14



<TABLE> <S> <C>

<ARTICLE> 5

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               SEP-30-2000
<CASH>                                      16,453,915
<SECURITIES>                                         0
<RECEIVABLES>                                   67,056
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                            16,628,865
<PP&E>                                       2,010,147
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                              19,837,997
<CURRENT-LIABILITIES>                        1,038,934
<BONDS>                                              0
                                0
                                          0
<COMMON>                                       249,171
<OTHER-SE>                                  16,778,394
<TOTAL-LIABILITY-AND-EQUITY>                19,837,995
<SALES>                                        257,280
<TOTAL-REVENUES>                               421,911
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                             4,608,151
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                 153
<INCOME-PRETAX>                            (3,515,380)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                        (3,515,380)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                               (3,515,380)
<EPS-BASIC>                                     (0.15)
<EPS-DILUTED>                                   (0.15)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission